$0.00
(0.00%)
| Today's Open | $65.95 |
|---|---|
| Previous Close | $66.00 |
| Daily Range | $64.07 - $66.95 |
| 52-Week Range | $62.34 - $110.79 |
| Market Cap | $7.3B |
| P/E Ratio | 20.82 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,090,650 |
| Average Daily Volume | 1,864,538 |
| Current FY EPS | $3.05 |
Sector
Healthcare
Industry
Healthcare Information Services
Edwards Lifesciences Corp (EW) Description
A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. Website: http://www.edwards.com/
News & Commentary
Wall Street continues its remarkable rally, but these three companies can't seem to enjoy the run
Why This Big Buyback Isn't a Long-Term Solution
Edwards Lifesciences announces a $750 million repurchase plan, but is this move ignoring its real problems?Edwards Lifesciences CFO to Retire
Thomas Abate will step down later this year.
A roundup of the day's best performers within the S&P 500, and what their moves mean for investors.
These 4 Stocks Have Held the S&P 500 Back
The S&P has advanced to record highs, but these stocks have fallen dramatically.EW's Top Competitors
(-2.58%)
(-1.57%)
(-0.84%)